Hospital
The First Affiliated Hospital of Harbin Medical University哈尔滨医科大学附属第一医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A General list, 2023
-
Published research 19 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 3 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 哈尔滨医科大学附属第一医院
- English name
- The First Affiliated Hospital of Harbin Medical University
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Fudan specialty reputation ranking 2023
- General Surgery nominated https://www.fdygs.com/news2023-1.aspx
Published research
- CAF-derived exosomes inhibit ferroptosis via GALNT14-mediated O-GalNAcylation of SLC7A11 in colorectal cancer. Oncogene, 2026
PubMed indexes 1 paper on this condition that names this hospital.
-
Breast cancer
Published research
- Immune-metabolic profiling of triple-negative breast cancer during neoadjuvant chemotherapy. iScience, 2026
- UBE2L6 promotes invasion and metastasis of triple-negative breast cancer by enhancing autophagy through STK38 ISGylation. Cellular and molecular life sciences : CMLS, 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Lung cancer
Published research
- Silencing of BCAT1 induces ferroptosis and inhibits brain metastasis of non-small cell lung cancer via activating the cGAS-STING pathway. Journal of thoracic disease, 2026
- Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis. Lung cancer (Amsterdam, Netherlands), 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Liver cancer
Published research
- A tumor-resident Staphylococcus epidermidis strain exhibits genomic and metabolic traits driving hepatocellular carcinoma progression. iScience, 2026
- Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Stomach cancer
Published research
- Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection. Frontiers in immunology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Prostate cancer
Published research
- CCNA2 orchestrates the PI3K/AKT signaling axis to propel prostate cancer metastasis. Translational andrology and urology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Thyroid cancer
Published research
- RNF123 Inhibits the Proliferation, Migration, and Invasion of Thyroid Cancer by Inhibiting KAT5-Mediated PSPC1 Histone Acetylation. Molecular carcinogenesis, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Esophageal cancer
Published research
- Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanism. Translational cancer research, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: General Surgery nominated in the Fudan list.
-
Pancreatic cancer
Fudan specialty reputation ranking 2023
- General Surgery nominated https://www.fdygs.com/news2023-1.aspx
Other hospitals in Harbin
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24